A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinacalcet for the Treatment of Hypercalcaemia in Subjects With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Trial Profile

A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinacalcet for the Treatment of Hypercalcaemia in Subjects With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Feb 2016

At a glance

  • Drugs Cinacalcet (Primary)
  • Indications Hypercalcaemia; Primary hyperparathyroidism
  • Focus Registrational; Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 03 Jun 2014 New trial record
    • 04 Nov 2013
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top